{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T11:29:11Z","timestamp":1772450951329,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The relationship between serum lipids and cholecystitis is still under investigation. To examine the causal effect of serum lipids on cholecystitis using the Mendelian randomization method.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted univariable Mendelian randomization (MR) analyses using summary statistics from two independent genome-wide association studies (GWAS) on serum lipids (n\u2009=\u2009132,908) and cholecystitis (n\u2009=\u2009361,194). Mainly, the inverse-variance weighted (IVW) method was utilized to combine each SNP\u2019s causal estimation, and the MR-Egger was adopted as a complementary method, together with the weighted median. Cochrane\u2019s Q value was employed to appraise heterogeneity. The MR-Egger intercept and MR-PRESSO were used to detect the horizontal pleiotropy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our univariable results displayed a minor protective effect of serum low-density lipoprotein (LDL) cholesterol (OR [95% CI]\u2009=\u20090.9984483 [0.9984499, 0.9984468]; <jats:italic>p<\/jats:italic>\u2009=\u20090.008) on cholecystitis. No significant causal effect of total cholesterol (TC) (OR [95% CI]\u2009=\u20090.9994228 [0.9994222, 0.9994233]; <jats:italic>p<\/jats:italic>\u2009=\u20090.296), triglycerides (OR [95% CI]\u2009=\u20090.9990893 [0.9990882, 0.9990903]; <jats:italic>p<\/jats:italic>\u2009=\u20090.238) and high-density lipoprotein (HDL) cholesterol (OR [95% CI]\u2009=\u20090.9997020 [0.9997017, 0.9997023]; <jats:italic>p<\/jats:italic>\u2009=\u20090.565) was found on cholecystitis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These findings suggest that LDL cholesterolhas a slight protective effect on cholecystitis, which can be easily affected by confounding factors. TC, triglycerides and HDL cholesterol don\u2019t have causal effect on cholecystitis. The protective effect of serum lipids on cholecystitis, though possible, remain less certain.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-021-01082-y","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T04:03:09Z","timestamp":1631851389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Mendelian randomization rules out the causal relationship between serum lipids and cholecystitis"],"prefix":"10.1186","volume":"14","author":[{"given":"Hongqun","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanlan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengnan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kezhen","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zehan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yahui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"issue":"6","key":"1082_CR1","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.bpg.2006.05.004","volume":"20","author":"EA Shaffer","year":"2006","unstructured":"Shaffer EA. Gallstone disease: epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol. 2006;20(6):981\u201396.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"6","key":"1082_CR2","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.suc.2008.07.008","volume":"88","author":"DR Elwood","year":"2008","unstructured":"Elwood DR. Cholecystitis. Surg Clin North Am. 2008;88(6):1241\u201352, viii.","journal-title":"Surg Clin North Am"},{"issue":"1","key":"1082_CR3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/oxfordjournals.aje.a115995","volume":"134","author":"GC Mohr","year":"1991","unstructured":"Mohr GC, Kritz-Silverstein D, Barrett-Connor E. Plasma lipids and gallbladder disease. Am J Epidemiol. 1991;134(1):78\u201385.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"1082_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12944-019-1184-3","volume":"19","author":"J Wang","year":"2020","unstructured":"Wang J, Shen S, Wang B, Ni X, Liu H, Ni X, Yu R, Suo T, Liu H. Serum lipid levels are the risk factors of gallbladder stones: a population-based study in China. Lipids Health Dis. 2020;19(1):50.","journal-title":"Lipids Health Dis"},{"issue":"19","key":"1082_CR5","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017;318(19):1925\u20136.","journal-title":"JAMA"},{"issue":"1","key":"1082_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"GD Smith","year":"2003","unstructured":"Smith GD, Ebrahim S. \u201cMendelian randomization\u201d: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32(1):1\u201322.","journal-title":"Int J Epidemiol"},{"issue":"9","key":"1082_CR7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/eurheartj\/eht571","volume":"36","author":"MV Holmes","year":"2015","unstructured":"Holmes MV, Asselbergs FW, Palmer TM, Drenos F, Lanktree MB, Nelson CP, Dale CE, Padmanabhan S, Finan C, Swerdlow DI, et al. Mendelian randomization of blood lipids for coronary heart disease. Eur Heart J. 2015;36(9):539\u201350.","journal-title":"Eur Heart J"},{"issue":"11","key":"1082_CR8","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.2797","volume":"45","author":"CJ Willer","year":"2013","unstructured":"Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, Kanoni S, Ganna A, Chen J, Buchkovich ML, Mora S, et al. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45(11):1274\u201383.","journal-title":"Nat Genet"},{"issue":"5","key":"1082_CR9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693\u20138.","journal-title":"Nat Genet"},{"issue":"1","key":"1082_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/ije\/dyh048","volume":"33","author":"DC Thomas","year":"2004","unstructured":"Thomas DC, Conti DV. Commentary: the concept of \u201cMendelian randomization.\u201d Int J Epidemiol. 2004;33(1):21\u20135.","journal-title":"Int J Epidemiol"},{"issue":"7","key":"1082_CR11","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658\u201365.","journal-title":"Genet Epidemiol"},{"issue":"5","key":"1082_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32(5):377\u201389.","journal-title":"Eur J Epidemiol"},{"issue":"7109","key":"1082_CR13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"issue":"4","key":"1082_CR14","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S0022-2275(20)40064-1","volume":"36","author":"T Juvonen","year":"1995","unstructured":"Juvonen T, Savolainen MJ, Kairaluoma MI, Lajunen LH, Humphries SE, Kes\u00e4niemi YA. Polymorphisms at the apoB, apoA-I, and cholesteryl ester transfer protein gene loci in patients with gallbladder disease. J Lipid Res. 1995;36(4):804\u201312.","journal-title":"J Lipid Res"},{"issue":"Pt 1","key":"1082_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1042\/bj3360033","volume":"336","author":"M Fuchs","year":"1998","unstructured":"Fuchs M, Lammert F, Wang DQ, Paigen B, Carey MC, Cohen DE. Sterol carrier protein 2 participates in hypersecretion of biliary cholesterol during gallstone formation in genetically gallstone-susceptible mice. Biochem J. 1998;336(Pt 1):33\u20137.","journal-title":"Biochem J"},{"issue":"10","key":"1082_CR16","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3748\/wjg.v10.i10.1508","volume":"10","author":"ZY Jiang","year":"2004","unstructured":"Jiang ZY, Han TQ, Suo GJ, Feng DX, Chen S, Cai XX, Jiang ZH, Shang J, Zhang Y, Jiang Y, et al. Polymorphisms at cholesterol 7alpha-hydroxylase, apolipoproteins B and E and low density lipoprotein receptor genes in patients with gallbladder stone disease. World J Gastroenterol. 2004;10(10):1508\u201312.","journal-title":"World J Gastroenterol"},{"issue":"6444","key":"1082_CR17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/bmj.289.6444.521","volume":"289","author":"RK Scragg","year":"1984","unstructured":"Scragg RK, Calvert GD, Oliver JR. Plasma lipids and insulin in gall stone disease: a case-control study. Br Med J (Clin Res Ed). 1984;289(6444):521\u20135.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"6303","key":"1082_CR18","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1136\/bmj.283.6303.1352","volume":"283","author":"JR Thornton","year":"1981","unstructured":"Thornton JR, Heaton KW, Macfarlane DG. A relation between high-density-lipoprotein cholesterol and bile cholesterol saturation. Br Med J (Clin Res Ed). 1981;283(6303):1352\u20134.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"1","key":"1082_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1194\/jlr.M500180-JLR200","volume":"47","author":"KJ van Erpecum","year":"2006","unstructured":"van Erpecum KJ, Wang DQ, Moschetta A, Ferri D, Svelto M, Portincasa P, Hendrickx JJ, Schipper M, Calamita G. Gallbladder histopathology during murine gallstone formation: relation to motility and concentrating function. J Lipid Res. 2006;47(1):32\u201341.","journal-title":"J Lipid Res"},{"issue":"5","key":"1082_CR20","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1136\/jcp.40.5.524","volume":"40","author":"MR Jacyna","year":"1987","unstructured":"Jacyna MR, Ross PE, Bakar MA, Hopwood D, Bouchier IA. Characteristics of cholesterol absorption by human gall bladder: relevance to cholesterolosis. J Clin Pathol. 1987;40(5):524\u20139.","journal-title":"J Clin Pathol"},{"issue":"17","key":"1082_CR21","doi-asserted-by":"publisher","first-page":"7729","DOI":"10.1073\/pnas.92.17.7729","volume":"92","author":"B Khanuja","year":"1995","unstructured":"Khanuja B, Cheah YC, Hunt M, Nishina PM, Wang DQ, Chen HW, Billheimer JT, Carey MC, Paigen B. Lith1, a major gene affecting cholesterol gallstone formation among inbred strains of mice. Proc Natl Acad Sci U S A. 1995;92(17):7729\u201333.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1082_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S0022-2275(20)31676-X","volume":"42","author":"P Mardones","year":"2001","unstructured":"Mardones P, Qui\u00f1ones V, Amigo L, Moreno M, Miquel JF, Schwarz M, Miettinen HE, Trigatti B, Krieger M, VanPatten S, et al. Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice. J Lipid Res. 2001;42(2):170\u201380.","journal-title":"J Lipid Res"},{"issue":"16","key":"1082_CR23","doi-asserted-by":"publisher","first-page":"9322","DOI":"10.1073\/pnas.96.16.9322","volume":"96","author":"B Trigatti","year":"1999","unstructured":"Trigatti B, Rayburn H, Vi\u00f1als M, Braun A, Miettinen H, Penman M, Hertz M, Schrenzel M, Amigo L, Rigotti A, et al. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci U S A. 1999;96(16):9322\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"26","key":"1082_CR24","doi-asserted-by":"publisher","first-page":"23699","DOI":"10.1074\/jbc.M211233200","volume":"278","author":"M Van Eck","year":"2003","unstructured":"Van Eck M, Twisk J, Hoekstra M, Van Rij BT, Van der Lans CA, Bos IS, Kruijt JK, Kuipers F, Van Berkel TJ. Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver. J Biol Chem. 2003;278(26):23699\u2013705.","journal-title":"J Biol Chem"},{"issue":"2","key":"1082_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1388-1981(02)00194-4","volume":"1583","author":"DQ Wang","year":"2002","unstructured":"Wang DQ, Carey MC. Susceptibility to murine cholesterol gallstone formation is not affected by partial disruption of the HDL receptor SR-BI. Biochim Biophys Acta. 2002;1583(2):141\u201350.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"1082_CR26","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/S0016-5085(19)32470-9","volume":"69","author":"G Salen","year":"1975","unstructured":"Salen G, Nicolau G, Shefer S, Mosbach EH. Hepatic cholesterol metabolism in patients with gallstones. Gastroenterology. 1975;69(3):676\u201384.","journal-title":"Gastroenterology"},{"issue":"2","key":"1082_CR27","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1365-2362.1984.tb02105.x","volume":"14","author":"K von Bergmann","year":"1984","unstructured":"von Bergmann K, Leiss O. Effect of short-term treatment with bezafibrate and fenofibrate on biliary lipid metabolism in patients with hyperlipoproteinaemia. Eur J Clin Investig. 1984;14(2):150\u20134.","journal-title":"Eur J Clin Investig"},{"issue":"12","key":"1082_CR28","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.2460\/ajvr.78.12.1406","volume":"78","author":"T Kakimoto","year":"2017","unstructured":"Kakimoto T, Kanemoto H, Fukushima K, Ohno K, Tsujimoto H. Effect of a high-fat-high-cholesterol diet on gallbladder bile acid composition and gallbladder motility in dogs. Am J Vet Res. 2017;78(12):1406\u201313.","journal-title":"Am J Vet Res"},{"issue":"3","key":"1082_CR29","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/ajcn\/39.3.356","volume":"39","author":"WP Hopman","year":"1984","unstructured":"Hopman WP, Jansen JB, Rosenbusch G, Lamers CB. Effect of equimolar amounts of long-chain triglycerides and medium-chain triglycerides on plasma cholecystokinin and gallbladder contraction. Am J Clin Nutr. 1984;39(3):356\u20139.","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"1082_CR30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/nmo.12094","volume":"25","author":"J Behar","year":"2013","unstructured":"Behar J, Mawe GM, Carey MC. Roles of cholesterol and bile salts in the pathogenesis of gallbladder hypomotility and inflammation: cholecystitis is not caused by cystic duct obstruction. Neurogastroenterol Motil. 2013;25(4):283\u201390.","journal-title":"Neurogastroenterol Motil"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-021-01082-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-021-01082-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-021-01082-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T04:03:20Z","timestamp":1631851400000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-021-01082-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1082"],"URL":"https:\/\/doi.org\/10.1186\/s12920-021-01082-y","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,17]]},"assertion":[{"value":"8 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have consented for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"224"}}